Celon Pharma Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-122.39	-34.45	-28.12	-39.28	-11.61	-0.92
Depreciation & Amortization	47.97	51.15	48.95	42.43	39.38	29.59
Other Amortization	1.09	0.71	1.06	1.67	1.96	2.18
Loss (Gain) From Sale of Assets	-0.02	-7.64	-10.95	-3.48	-0.13	0.32
Loss (Gain) From Sale of Investments	-9.74	-9.74	-	-	-	-
Other Operating Activities	83.92	0.16	11.86	2.56	0.28	-2.95
Change in Accounts Receivable	-5.36	-1.64	-12.54	-6.46	13.24	2.42
Change in Inventory	4.44	-3.77	11.98	-15.01	6.38	0.3
Change in Other Net Operating Assets	2.84	-6.12	-30.55	12.87	-5.56	40.8
Operating Cash Flow	0.47	-11.34	-8.31	-4.7	43.95	71.74
Operating Cash Flow Growth	-	-	-	-	-38.73%	-
Capital Expenditures	-41.7	-22.79	-32.81	-33.91	-41.35	-99.48
Sale of Property, Plant & Equipment	0.34	0.68	1.24	0.59	0.17	0.63
Cash Acquisitions	-12.42	-16.36	-	-	-	-
Investment in Securities	79.38	40	9.5	-	-79.87	45.44
Other Investing Activities	0.02	0.06	0.43	1.85	-	0.14
Investing Cash Flow	11.29	-7.49	-21.64	-31.47	-121.05	-53.27
Short-Term Debt Issued	-	1.53	12.75	-	-	12.84
Total Debt Issued	1.53	1.53	12.75	-	-	12.84
Short-Term Debt Repaid	-	-12.75	-	-	-12.84	-
Long-Term Debt Repaid	-	-9.69	-26.13	-12.43	-4.8	-4.4
Total Debt Repaid	-11.86	-22.44	-26.13	-12.43	-17.64	-4.4
Net Debt Issued (Repaid)	-10.33	-20.91	-13.37	-12.43	-17.64	8.44
Issuance of Common Stock	-	40.51	0	0	216	-
Common Dividends Paid	-4.09	-4.09	-4.6	-14.8	-3.15	-3.6
Other Financing Activities	-1.68	-2.19	-2.62	-1.5	-14.3	-0.59
Financing Cash Flow	-16.09	13.32	-20.59	-28.72	180.91	4.25
Miscellaneous Cash Flow Adjustments	-0	-0	-	-	-	-
Net Cash Flow	-4.34	-5.51	-50.54	-64.89	103.82	22.72
Free Cash Flow	-41.23	-34.13	-41.13	-38.61	2.6	-27.74
Free Cash Flow Margin	-18.28%	-16.61%	-19.16%	-19.91%	1.33%	-17.62%
Free Cash Flow Per Share	-0.79	-0.65	-0.81	-0.76	0.06	-0.62
Cash Interest Paid	1.68	2.19	2.62	1.5	0.94	0.59
Cash Income Tax Paid	-	-1.07	-0.97	-0.52	-	-1.28
Levered Free Cash Flow	-76.76	-23.92	-34.98	-18.83	-1.33	4.24
Unlevered Free Cash Flow	-75.55	-22.38	-33.32	-17.79	-0.36	4.66
Change in Working Capital	1.92	-11.53	-31.11	-8.6	14.07	43.52

Source: S&P Global Market Intelligence. Standard template. Financial Sources.